Background : We recently reported that acute retinal necrosis in humans develops in a setting where delayed hypersensitivity (DH) to the varicella-zoster virus (VZV) antigen was absent, implying that virus-specific DH mitigates against acute retinal necrosis.
O UR LABORATORY and clinical group has been interested in probing the possible relationships between reactivated varicella-zoster virus (VZV) infection, delayed hypersensitivity (DH) to VZV antigens, and the presence of VZV-related eye diseases. Previously, we showed in a group of patients with acute ocular inflammation secondary to reactivated VZV infection, 1 that a high proportion of patients with VZV-induced acute retinal necrosis displayed a transient loss of virus-specific DH, while their serum samples contained high titers of anti-VZV antibodies. Upon resolution of the intraocular inflammation, virus-specific DH was once again detectable in most of these individuals.
Varicella-zoster virus infections display a bimodal age distribution. Children may contract the virus through inhaled viral particles, which results in a generalized vesicular rash (chickenpox). The virus may then reside dormant in sensory nerve ganglia for many years. A second peak in the distribution of infection occurs in the elderly. This may represent a reactivation of the virus in the setting of declining cellular immunity. 2 The oph-LABORATORY SCIENCES thalmic division is the most frequently affected branch of the trigeminal nerve, 3 and when VZV in this branch is reactivated, it can affect various ocular tissues, causing blepharitis, conjunctivitis, scleritis, keratitis, anterior uveitis, vitritis, and retinitis.
Recovering virus from aqueous humor aids in making the diagnosis of isolated herpetic iridocyclitis, 4 and almost invariably, the uveitis is on the same side as the affected trigeminal branch. Uveitis caused by VZV is an extremely common manifestation of recurrent disease. In some cases, virus particles have been found in the anterior chamber and may contribute to the uveitis. 5 However, the exact cause of the iridocyclitis is not known, and both viral toxic and immunopathogenic mechanisms have been considered. In the current study, we report that the clinical intensity of anterior uveitis caused by VZV correlated negatively with VZV DH responses, and this correlation reached statistical significance. Therefore, impaired VZV DH reactivity in patients with high-intensity VZV-induced uveitis suggests that the emergence of VZVinduced uveitis during acute VZV reactivation may be dependent on the attenuation of DH reactivity to VZV. A similar inverse correlation exists between VZV-induced acute retinal necrosis and virus-specific DH.
PATIENTS AND METHODS

PATIENTS
Twelve patients with acute anterior uveitis with VZV-induced facial skin disease (herpes zoster ophthalmicus [ZO-AU] group; mean±SD age: 49.6±18.2 years) were selected from the patient population with uveitis at the Department of Ophthalmology, Tokyo Medical University Hospital from 1999 to 2001. Three patients with acute anterior uveitis caused by VZV without VZV-induced facial skin disease (zoster sine herpete [ZSH-AU] group) were also selected. Seven age-matched patients with VZV-infection of the facial skin who displayed no uveitis (ophthalmic herpes zoster without uveitis group) were chosen as VZV-infected controls. In addition, 6 patients with Vogt-Koyanagi-Harada disease or HLA-B27-positive acute anterior uveitis were selected as noninfected controls.
SAMPLES
All cases of serum samples and some cases of aqueous humor in patients with anterior uveitis with VZV-like facial skin disease were collected at the first visit to the clinic. Similar samples were collected from patients with anterior uveitis without facial skin disease as a means to determine the presence of VZV infection. Informed consent was obtained from each patient before skin test assays were performed.
POLYMERASE CHAIN REACTION
For the diagnosis of anterior uveitis caused by VZV, polymerase chain reaction (PCR) methods were performed by the technique described by Saiki et al, 6 Usui et al, 7 and Kezuka et al. 1
ASSAY OF ANTI-VZV ANTIBODY TITERS IN SERUM SAMPLES
For help with the diagnosis of anterior uveitis caused by VZV, viral antibody titers of serum samples were determined by the fluorescent antibody technique.
SKIN TEST ASSAY OF DH
At their first visit to the clinic, and before systemic steroid therapy and an antiviral agent regimen were instituted, 14 patients with ZO-AU and ZSH-AU, as controls, 8 age-matched patients with VZV infection of the facial skin who displayed no uveitis, and 5 patients with Vogt-Koyanagi-Harada disease or HLA-B27positive acute anterior uveitis, were skin tested with 0.1 mL of VZV antigen (Tanabe Co, Osaka, Japan) 8 and purified protein derivative (PPD) (Takeda Co, Osaka) antigens. Delayed hypersensitivity reactions were evaluated 24 and 48 hours after the first visit to the clinic. Skin tests were performed using the technique described by Kezuka et al. 1 In detail, we used varicella virus of Kawaguchi strain for the preparation of skin antigen. The test antigen preparation includes VZV glycoproteins (gp 3 and gp 5) (80-100 µg/mL). We used PPD tuberculin (0.5 µg/mL), an antigen derived from the tubercle bacillus, as the positive control antigen for skin tests. Positive responses were characterized by cutaneous erythema at the injection sites, measuring greater than 5 mm in diameter at 24 hours and 48 hours for VZV antigen 8 ; and greater than 10 mm in diameter at 48 hours for PPD antigen. In some patients, the VZV skin test was repeated 3 months after the initial onset of intraocular disease.
CLINICAL EVALUATION OF ANTERIOR UVEITIS CAUSED BY VZV
At the first visit to the clinic, all patients with anterior uveitis caused by VZV were divided into a "2+" (ie, severe) group and a "1+" (ie, mild) group. The severity of disease in these patients proved to be greatest on the day of their initial clinic visit, which typically occurred a few days (or less) after the onset of disease. The observers were 2 of us (T.K. and J.S.), who each time evaluated anterior chamber cells and flare using the modified grading system described by Hogan et al. 9 In fact, Hogan and colleagues proposed the grading system of evaluation of uveitis that used an approximately 1ϫ1-mm slit beam. They graded anterior chamber cells and flare on a scale of 0 to 4+. We modified their system as follows: 1+ indicates "mild uveitis" (equivalent to their grades 1+ and 2+) and 2+ indicates "severe uveitis" (equivalent to their grades 3+ and 4+). In specific detail, using a 1ϫ1-mm slit beam, we considered 1+ as "mild uveitis," with 5 to 20 cells in the anterior chamber, moderate anterior chamber flare (iris and lens images are clear), and no large keratic precipitates; we considered 2+ as "severe uveitis," with 20 cells in the anterior chamber, marked flare (iris and lens images are hazy) in the anterior chamber, and large keratic precipitates on the corneal endothelium. No patients had received topical treatment prior to their first visit to our clinic, and treatment with topical corticosteroids was administered after the first medical examination. No patients had a history of corticosteroid-induced elevation of intraocular pressure (IOP). Within 2 weeks after the first visit, the IOP of patients with VZV-induced acute anterior uveitis was measured.
Intraocular pressure values in excess of 21 mm Hg were considered diagnostic of secondary glaucoma. Differences between groups to be compared were analyzed by Mann-Whitney U test; P Ͻ .05 was considered to be significant.
RESULTS
CHARACTERISTICS OF PATIENTS WITH VZV-AU AND THEIR CONTROLS
Fourteen patients selected from a clinical population with uveitis were selected for study ( Table 1 ). These pa-(REPRINTED) ARCH OPHTHALMOL / VOL 120, SEP 2002 tients were diagnosed with uveitis caused by VZV and included patients from the ZSH group. Within this group, the uveitis of 8 patients was categorized as severe, while that of 4 others was categorized as mild. Based on history, these patients first visited the clinic within 2 to 37 days after the onset of skin disease, except for those in the ZSH-AU group. Serum samples were collected during the acute phase of the disease. The formal diagnosis of VZV-AU was established by the titer of anti-VZV antibody, and in cases of patients with ZSH, the diagnosis was established by PCR analysis using the aqueous humor (data not presented).
VZV-SPECIFIC DH IN PATIENTS WITH ZO-AU
To investigate the relationship between cell-mediated immune responses to the VZV antigen and the presence of ZO-AU, we performed skin testing for patients with VZV-AU and ophthalmic herpes zoster without uveitis with VZV antigens. The results of this study are presented in Table 2 . There was no significant difference between 24-hour and 48-hour erythema responses in any of the subjects. All 7 patients in the control group displayed intense DH when tested with VZV antigen. By contrast, only 1 (12.5%) of 8 patients with severe ZO-AU displayed a positive VZV skin test. Moreover, 3 (75.0%) of 4 patients with mild ZO-AU displayed a positive VZV skin test. The clinical intensity of anterior uveitis correlated negatively with VZV DH responses (PϽ.05), and the difference between DH responses in patients with ZO-AU as compared with patients with ophthalmic herpes zoster without uveitis is statistically significant (PϽ.001).
Thus, patients with ZO-AU have a very high probability of displaying no virus-specific DH at the time of diagnosis, unlike in VZV-infected patients without uveitis, whose DH to VZV antigens is uniformly intense.
COMPARISON OF DH TO VZV AND PPD IN PATIENTS WITH ZO-AU
The impaired DH to VZV antigens demonstrated above can be explained in 2 ways. (1) Patients with ZO-AU suffer from a global loss of DH reactivity to many (or all) antigens; and (2) patients with ZO-AU suffer from a selective loss of DH reactivity to VZV viral antigens, but not to other antigens. To discriminate between these possibilities, each patient was also skin tested with PPD, an antigenic preparation derived from the tubercle bacillus *VZV indicates varicella-zoster virus; PPD, purified protein derivative; HSV, herpes simplex virus; IOP, intraocular pressure; ZO-AU, VZV-induced anterior uveitis (herpes zoster ophthalmicus); ZSH-AU, VZV-induced anterior uveitis without skin disease (zoster sine herpete); SD, facial skin disease induced by VZV (herpes zoster ophthalmicus); ND, test not done; and ellipses, unknown. Plus and minus signs indicate the presence or absence, respectively, of a given symptom. †PϽ.05 (ZO-AU mild type vs ZO-AU severe type). ‡PϽ.001 (ZO-AU severe type vs skin disease with VZV infection).
Table 2. Delayed Hypersensitivity Responses Elicited by the VZV Antigen in Patients With
(REPRINTED) ARCH OPHTHALMOL / VOL 120, SEP 2002 that is not cross-reactive with VZV antigens. As described previously, vaccination with BCG is very common in Japan, and as a consequence, a high proportion of normal individuals possesses DH directed at PPD (approximately 95% are PPD positive). Thus, 95% of our patients, irrespective of diagnosis, should be PPD positive.
The results of PPD skin tests among our patients with ZO-AU are presented in Table 1 and Table 3 . All 7 patients with VZV-induced skin disease alone (controls) displayed intense DH when tested with the PPD antigen. Similarly, 11 (91.6%) of 12 patients with uveitis displayed positive PPD skin test reactions. These results indicate that patients with ZO-AU possess DH toward PPD at the same frequency as controls. Thus, the impaired DH to VZV antigens observed in patients with both mild and severe ZO-AU seems to be selective and limited to the antigens derived from VZV.
COMPARISON OF VIRUS-SPECIFIC CELLULAR AND HUMORAL IMMUNE RESPONSES IN PATIENTS WITH ZO-AU
Acute retinal necrosis caused by VZV correlates positively with an elevation of serum anti-VZV antibody titers. We have previously reported that the magnitude of the anti-VZV antibody response in these patients is inversely proportional to their ability to display VZVspecific DH. 1 We wondered if patients with ZO-AU with impaired VZV-specific DH might resemble patients with acute retinal necrosis in this manner. We analyzed the titers of anti-VZV and anti-herpes simplex virus anti-bodies in serum samples from patients with ZO-AU using a fluorescent antibody technique. Serum samples collected from patients with VZV skin disease without uveitis served as controls. As the data presented in Table 1 and Table 4 reveal, anti-VZV and anti-herpes simplex virus serum antibody titers were comparable in DHpositive and DH-negative patients with ZO-AU. This result indicates that ZO-AU is associated with elevated serum anti-VZV antibody titers, and that the magnitude of the antibody titer is not related to the ability of these patients to display VZV-specific DH.
COMPARISON OF IOP ELEVATION IN PATIENTS WITH ZO-AU
The results presented thus far can be interpreted to mean that the presence of DH directed at VZV antigens protects against the development of severe ZO-AU in patients infected with the virus. Elevated IOP is a characteristic feature of acute ZO-AU. Using this as an indicator of the presence of AU, we measured the IOP of patients with ZO-AU and compared their levels with the presence or absence of virus-specific DH. The results are displayed in 
VZV-SPECIFIC DH IN PATIENTS WITH ZSH
To test the validity of this suggestion, we examined VZV DH responses in patients with VZV without dermatitis (ZSH). In our experience, diagnosing uveitis caused by VZV in the absence of an attendant dermatitis is difficult. Along with VZV skin testing for patients with ZSH, we also skin tested patients with Vogt-Koyanagi-Harada disease or HLA-B27-positive acute anterior uveitis as controls. We skin tested 3 patients with ZSH, in whom VZV DNA was detected in aqueous humor samples using the PCR (data not presented). As presented in Table 6 , these patients with ZSH failed to display VZV-specific DH, whereas 5 (83%) of 6 patients with Vogt-Koyanagi-Harada disease or HLA-B27-positive acute anterior uveitis responded to VZV antigens. As anticipated, PPD responses of patients with ZSH were normal (Table 1) . *VZV indicates varicella-zoster virus; ZSH-AU, VZV-induced anterior uveitis without skin disease (zoster sine herpete); DH−, negative delayed hypersensitivity to VZV antigen; DH+, positive delayed hypersensitivity to VZV antigen.
(REPRINTED) ARCH OPHTHALMOL / VOL 120, SEP 2002 necrosis is a retinal infection. In the mouse system, BALB/c mice that receive an anterior chamber injection of an antigen acquire an unusual systematic immune response, termed "anterior chamber-associated immune deviation" (ACAID). 19, 20 In this system, impaired antigen-specific DH coexists with high serum titers of antigen-specific antibodies. The results presented in this article serve to support our hypothesis that anterior chamber-associated immune deviation may be the immunologic mechanism that is triggered in the eyes of some patients undergoing idiopathic reactivation of VZV in the trigeminal ganglion. For reasons yet to be revealed, zosteriform spread of antigenic VZV particles to the anterior chamber leads to suppression of virusspecific T cells that mediate DH, and by so doing, rob the eye of the protection afforded by these CD4 + T cells. Acute viral infection of sensitive intraocular tissues ranging from iris to retina is the inevitable consequence. If we could understand how to abort anterior chamberassociated immune deviation in this situation, intraocular complications of ophthalmic herpes zoster might be eliminated from clinical ophthalmology. October 2, 2001;  final revision received April 24, 2002; accepted May 16, 2002. Corresponding author: Takeshi Kezuka, MD, PhD, Department of Ophthalmology, Hachioji Medical Center, Tokyo Medical University, 1163, Tate-machi, Hachioji-city, Tokyo, 193-8639, Japan (e-mail: tkezuka@tokyo-med.ac.jp).
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